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Genome-wide association studies (GWAS) have identified tens of thousands of genetic variants associated with hundreds of
phenotypes and diseases, which have provided clinical and medical benefits to patients with novel biomarkers and therapeutic
targets. Recently, there has been accumulating evidence suggesting that different complex traits share a common risk basis,
namely, pleiotropy. Previously, a statistical method, namely, GPA (Genetic analysis incorporating Pleiotropy and Annotation), was
developed to improve identification of risk variants and to investigate pleiotropic structure through a joint analysis of multiple
GWAS datasets. While GPA provides a statistically rigorous framework to evaluate pleiotropy between phenotypes, it is still not
trivial to investigate genetic relationships among a large number of phenotypes using the GPA framework. In order to address
this challenge, in this paper, we propose a novel approach, GPA-MDS, to visualize genetic relationships among phenotypes using
the GPA algorithm and multidimensional scaling (MDS). This tool will help researchers to investigate common etiology among
diseases, which can potentially lead to development of common treatments across diseases. We evaluate the proposed GPA-MDS
framework using a simulation study and apply it to jointly analyze GWAS datasets examining 18 unique phenotypes, which helps
reveal the shared genetic architecture of these phenotypes.
1. Introduction
Genome-wide association studies (GWAS) have been con-
ducted to study the genetic basis of complex human traits. As
of August 2015, more than 15,000 single nucleotide polymor-
phisms (SNPs) have been reported to be significantly asso-
ciated with at least one complex trait (the NHGRI-EBI cat-
alog of published GWAS [1], https://www.ebi.ac.uk/gwas/).
“Pleiotropy,” that is, the sharing of genetic factors among
complex traits, is well documented and a systematic analysis
of the GWAS catalog of published GWAS showed that 17%
of the reported genes are associated with multiple traits
[2]. For example, genetic studies for five psychiatric dis-
orders suggested a very strong genetic correlation between
schizophrenia and bipolar disorder [3, 4]. Pleiotropy has also
been demonstrated among several other types of traits, such
as cancers [5].
In order to leverage pleiotropy between complex traits
and effectively integrate multiple GWAS datasets, Chung et
al. [6] developed a unified statistical framework, named GPA
(Genetic analysis incorporating Pleiotropy and Annotation),
which provides statistically rigorous and biologically inter-
pretable inference tools for genetic studies. Application of
GPA to five psychiatric disorder GWAS datasets from the
Psychiatric Genomics Consortium [3, 4] showed that GPA
can accurately identify pleiotropic structure among these dis-
eases [6]. While the GPA framework provides a statistically
rigorous framework to evaluate pleiotropy, it still remains
limited to a small number of phenotypes and it is common
to consider a joint analysis of only two phenotypes mainly
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Figure 1: GPA-MDS framework. In this framework, by taking the association 𝑝-value for each SNP from each GWAS study as an input, we
first calculate a distance matrix between phenotypes using the pleiotropy hypothesis testing procedures in the GPA framework. Then, we
generate a plot depicting a global picture of genetic relationship among phenotypes by projecting phenotypes onto two-dimensional space
using the multidimensional scaling (MDS) algorithm based on this distance matrix.
due to computational efficiency and estimation stability and
robustness. In practice, we are interested in jointly studying
larger numbers of phenotypes; however it is not a trivial task
to investigate and integrate results from multiple pairs of
phenotypes.
In order to address this challenge, in this paper, we pro-
pose a novel visualization approach,GPA-MDS, to investigate
genetic architecture with a joint analysis of multiple GWAS
datasets using the GPA algorithm and the multidimensional
scaling (MDS) approach. Specifically, the GPA algorithm
allows for evaluation of pleiotropy between two phenotypes
within a statistically rigorous framework. Then, the MDS
approach effectively integrates these results for a large num-
ber of phenotypes and provides a two-dimensional map of
genetic architecture. This paper is organized as follows. In
Section 2, we review the GPA and MDS algorithms and
propose the GPA-MDS approach. In Section 3, we evaluate
the proposed method with a simulation study and apply it to
a joint analysis of 18 GWAS datasets. Finally, in Section 4, we
will discuss future research directions.
2. Methods: GPA-MDS Approach
Figure 1 shows a diagram of overall workflow for the GPA-
MDS framework. Here, by taking association 𝑝-value for
each SNP from each GWAS dataset as an input, we first
calculate a distance matrix between phenotypes using the
GPA framework, as described in detail in Section 2.1. Then,
we generate a plot of genetic relationship among phenotypes
using the multidimensional scaling (MDS) algorithm, as
illustrated in Section 2.2.
2.1. Statistical Inference of Pleiotropy Using the GPAAlgorithm.
In this section, we review the GPA framework [6] for the
case of a joint analysis of two GWAS datasets. Although there
is no limitation in the number of GWAS datasets that can
be jointly analyzed in the GPA framework, a joint analysis
of two GWAS datasets is often appropriate in the sense of
the computational efficiency and estimation stability and
robustness. Let 𝑡 be the index for SNPs and let 𝑘 be the
index for GWAS datasets. Suppose that we have performed
hypothesis testing of genome-wide SNPs for two GWAS and
obtained their 𝑝-values. Specifically, for GWAS1, we have
Null hypothesis for GWAS1: 𝐻
(11)
0 , 𝐻
(21)
0 , . . . , 𝐻
(𝑡1)
0 , . . . ,
𝐻(𝑀1)0 ,
𝑝-value for GWAS1: 𝑃11, 𝑃21, . . . , 𝑃𝑡1, . . . , 𝑃𝑀1,
(1)
where𝑀 is the number of SNPs and 𝑃𝑡𝑘 denotes 𝑝-value of
the 𝑡th SNP in the 𝑘th GWAS. Similarly, for GWAS2, we have
Null hypothesis for GWAS2: 𝐻
(12)
0 , 𝐻
(22)
0 , . . . , 𝐻
(𝑡2)
0 , . . . ,
𝐻(𝑀2)0 ,
𝑝-value for GWAS2: 𝑃12, 𝑃22, . . . , 𝑃𝑡2, . . . , 𝑃𝑀2.
(2)
Let us denote P1 = (𝑃11, 𝑃21, . . . , 𝑃𝑡1, . . . , 𝑃𝑀1) and P2 = (𝑃12,
𝑃22, . . . , 𝑃𝑡2, . . . , 𝑃𝑀2).
We introduce latent variables Z𝑡 = [𝑍𝑡00, 𝑍𝑡10, 𝑍𝑡01, 𝑍𝑡11]
indicating the association between the 𝑡th SNP and the two
phenotypes:𝑍𝑡00 = 1means that the 𝑡th SNP is not associated
with any phenotypes,𝑍𝑡10 = 1means that it is only associated
with the first one, 𝑍𝑡01 = 1 means that it is only associated
with the second one, and 𝑍𝑡11 = 1means that it is associated
with both. We assume that 𝑍𝑡00, 𝑍𝑡10, 𝑍𝑡01, 𝑍𝑡11 ∈ {0, 1} and
𝑍𝑡00 + 𝑍𝑡10 + 𝑍𝑡01 + 𝑍𝑡11 = 1 because a SNP can only be
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one of these states. Given these latent variables, we assume
the following emission distributions:
𝜋00 = Pr (𝑍𝑡00 = 1) :
(𝑃𝑡1 | 𝑍𝑡00 = 1) ∼ U [0, 1] , (𝑃𝑡2 | 𝑍𝑡00 = 1) ∼ U [0, 1] ,
𝜋10 = Pr (𝑍𝑡10 = 1) :
(𝑃𝑡1 | 𝑍𝑡10 = 1) ∼ Beta (𝛼1, 1) , (𝑃𝑡2 | 𝑍𝑡10 = 1) ∼ U [0, 1] ,
𝜋01 = Pr (𝑍𝑡01 = 1) :
(𝑃𝑡1 | 𝑍𝑡01 = 1) ∼ U [0, 1] , (𝑃𝑡2 | 𝑍𝑡01 = 1) ∼ Beta (𝛼2, 1) ,
𝜋11 = Pr (𝑍𝑡11 = 1) :
(𝑃𝑡1 | 𝑍𝑡11 = 1) ∼ Beta (𝛼1, 1) , (𝑃𝑡2 | 𝑍𝑡11 = 1) ∼ Beta (𝛼2, 1) ,
(3)
where 0 < 𝛼𝑘 < 1, 𝑘 = 1, 2. We put the constraint
0 < 𝛼𝑘 < 1 to model that a smaller 𝑝-value is more likely
than a larger 𝑝-value when it is from the nonnull group
[7]. Parameters in the GPA model can be estimated using
the Expectation-Maximization (EM) algorithm [8], which is
remarkably computationally efficient becausewehave explicit
solutions for all the parameters in the 𝑀-step. More details
about the GPA model, the EM algorithm, and the estimation
of standard errors can be found in [6].
Given the GPA model and its estimated parameters, we
can determine association of 𝑡th SNP with phenotypes based
on their local false discovery rate (FDR) [9]. Specifically, the
local FDR for association of 𝑡th SNPwith each of the first and
second phenotypes is defined as
fdr1 (𝑃𝑡1, 𝑃𝑡2) = Pr (𝑍𝑡00 + 𝑍𝑡01 = 0 | 𝑃𝑡1, 𝑃𝑡2) ,
fdr2 (𝑃𝑡1, 𝑃𝑡2) = Pr (𝑍𝑡00 + 𝑍𝑡10 = 0 | 𝑃𝑡1, 𝑃𝑡2) .
(4)
Similarly, the local FDR for association of 𝑡th SNP with both
phenotypes is defined as
fdr12 (𝑃𝑡1, 𝑃𝑡2) = Pr (𝑍𝑡00 + 𝑍𝑡10 + 𝑍𝑡01 = 0 | 𝑃𝑡1, 𝑃𝑡2) . (5)
Then, we use the direct posterior approach [10] to control the
global FDR. Specifically, we first sort SNPs by their local FDR
from the smallest one to the largest one. Denote these sorted
local FDR for 𝑡th SNP by 𝑓𝑡. We increase the threshold for
local FDR, 𝜅, from zero to one until
Fdr𝜅 =
∑𝑀𝑡=1 𝑓𝑡1 {𝑓𝑡 ≤ 𝜅}
∑𝑀𝑡=1 1 {𝑓𝑡 ≤ 𝜅}
≤ 𝜏, (6)
where 𝜏 is the predetermined bound of global FDR and 1{⋅}
is an indicator function with value of one if the statement is
true and of zero otherwise. Finally, we determine SNPs with
corresponding 𝑓𝑡 ≤ 𝜅 to be associated with the phenotype.
Now, consider testing pleiotropy between two pheno-
types. When the genetic bases of the two phenotypes are
independent of each other (i.e., no pleiotropy), then we
expect that 𝜋11 = (𝜋10 + 𝜋11)(𝜋01 + 𝜋11). Therefore, the
difference between 𝜋11 and (𝜋10 +𝜋11)(𝜋01 +𝜋11) can be used
to characterize pleiotropy. Hence, testing pleiotropy can be
formulated with the following hypothesis:
𝐻0: 𝜋11 = 𝜋1∗𝜋∗1, versus 𝐻1: not 𝐻0, (7)
where 𝜋1∗ = 𝜋10 + 𝜋11 and 𝜋∗1 = 𝜋01 + 𝜋11. The likelihood
ratio test (LRT) statistic can be constructed as follows:
𝜆 =
Pr (P1,P2; Θ̂0)
Pr (P1,P2; Θ̂)
, (8)
where Θ̂0 represents the parameter estimates obtained under
the null hypothesis of pleiotropy test. The test statistic
(−2 log 𝜆) asymptotically follows 𝜒2-distribution with degree
of freedom of one, under the null hypothesis. Fitting of the
GPA model and hypothesis testing of pleiotropy were imple-
mented as a part of the R package “GPA,” which is currently
available in its GitHub page (http://dongjunchung.github.io/
GPA/).
2.2. Visualization of Pleiotropic Structure Using Multidimen-
sional Scaling. For the visualization of genetic relationships
among phenotypes, we first run pleiotropy tests for all
possible pairs of GWAS datasets and generate a matrix of
their log10-transformed 𝑝-values, denoted as 𝑠𝑖𝑗. Then, we
define a distance between 𝑖th and 𝑗th phenotypes as 𝑑𝑖𝑗 =
𝑠𝑖𝑗 − 2min𝑘<𝑙{𝑠𝑘𝑙}. Note that this definition of distance
assigns a shorter distance to a pair of phenotypes with
smaller pleiotropy test 𝑝-values, while it also allows avoiding
negative distance values. Then, we feed this distance matrix
to the MDS algorithm and project phenotypes onto the
two-dimensional space. As a result, MDS essentially clus-
ters phenotypes based on their genetic similarities; that is,
phenotypes sharing fewer SNPs are located further apart on
the two-dimensional space compared to phenotypes sharing
more SNPs. Specifically, given a distance matrix 𝐷 = (𝑑𝑖𝑗),
MDS seeks to find 𝑥1, . . . , 𝑥𝑛 ∈ 𝑅𝑝 such that
𝑑𝑖𝑗 ≈ ?̂?𝑖𝑗 =
󵄩󵄩󵄩󵄩󵄩𝑥𝑖 − 𝑥𝑗
󵄩󵄩󵄩󵄩󵄩2 (9)
by minimizing the following objective function:
∑𝑖<𝑗 (𝑑𝑖𝑗 − ?̂?𝑖𝑗)
2
∑𝑖<𝑗 𝑑2𝑖𝑗
. (10)
Here, we consider 𝑝 = 2 to provide easily understandable
visualization. We used the function cmdscale() in R with
default settings to implement MDS.
3. Results
3.1. Simulation Study. We conducted a simulation study to
evaluate the performance of GPA-MDS approach. Here, we
assume that there are five GWAS datasets, each of which is
profiled for a set of 10,000 SNPs common to all 5 datasets.
Among these 10,000 SNPs, 2,000 SNPs (20%) were assumed
to be risk SNPs for each phenotype. In order to generate
pleiotropic structure, we set 75%of the risk SNPs to be shared
between phenotypes 1 and 2 and also between phenotypes 3
and 4, while no risk SNPs are shared between phenotypes
1/2 and phenotypes 3/4. Phenotype 5 did not share any
risk SNPs with any other phenotypes as a negative control
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Figure 2: Design of simulation study. Each box indicates a GWAS
study and 𝑥-axis represents the SNP index. The gray box within
each box indicates risk SNPs. In this study, we considered five
phenotypes and 20% of the SNPs were assumed to be risk SNPs for
each phenotype. We further assumed that 75% of risk SNPs were
shared between phenotypes 1 and 2 and also between phenotypes 3
and 4 to generate pleiotropic structure. Phenotype 5 did not share
any risk SNPs with any other phenotypes as a negative control.
1
2
3
4
5−20
−10
0
10
C
oo
rd
in
at
e 2
0 10 20−10
Coordinate 1
Figure 3: GPA-MDS plot for the simulation study.
(Figure 2). Finally, for each phenotype, we simulated𝑝-values
for nonrisk SNPs from a uniform distribution and 𝑝-values
for risk SNPs from a Beta distribution with parameters 0.4
and 1. Figure 3 shows the GPA-MDS plot for these five
phenotypes. In this plot, phenotypes 1 and 2 are clustered and
phenotypes 3 and 4 generate another cluster. Phenotype 5 is
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Figure 4: GPA-MDS plot for a joint analysis of genetic studies for
18 phenotypes.
isolated and located away from these two phenotype clusters.
This result shows that the proposed GPA-MDS approach
can provide easily interpretable visualization revealing the
pleiotropic architecture among phenotypes.
3.2. Real Data Analysis. We applied the proposed GPA-
MDS approach to the GWAS datasets of 18 phenotypes,
using summary statistics, which are publicly available from
consortiumwebsites. Specifically, we considered (1) attention
deficit/hyperactivity disorder (ADHD), autism spectrum
disorder (ASD), bipolar disorder (BPD), major depressive
disorder (MDD), and schizophrenia (SCZ) from the Psy-
chiatric Genomics Consortium (http://www.med.unc.edu/
pgc); (2) Crohn’s disease (CD) and ulcerative colitis (UC)
from the International Inflammatory Bowel Disease Genetics
Consortium (https://www.ibdgenetics.org/); (3) rheumatoid
arthritis (RA) (https://www.broadinstitute.org/ftp/pub/rheu-
matoid arthritis/Stahl etal 2010NG/); (4) high-density lipo-
protein (HDL), low-density lipoprotein (HDL), triglycerides
(TG), and total cholesterol (TC) from the Global Lipids
Consortium (http://csg.sph.umich.edu//abecasis/public/lip-
ids2010/); (5) type 2 diabetes (T2D) from the DIAbetes Ge-
netics Replication And Meta-analysis Consortium (http://
diagram-consortium.org/); (6) coronary artery disease
(CAD) from the CARDIoGRAM Consortium (http://www
.cardiogramplusc4d.org/data-downloads/); (7) systolic blood
pressure (SBP) and diastolic blood pressure (DBP) from the
International Consortium for Blood Pressure (http://www
.georgehretlab.org/icbp 088023401234-9812599.html); and
(8) fasting glucose (FG) and log of fasting insulin (LFI) from
the MAGIC Consortium. We used the intersection of SNPs
among these datasets, which consists of 228,944 SNPs.
Figure 4 shows the GPA-MDS plot for the 18 phenotypes.
We can see that clinically related phenotypes are tightly
International Journal of Genomics 5
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Figure 5: Heat map of shared risk SNPs for 18 phenotypes. Here,
“risk SNPs” were determined using the GPA algorithm by control-
ling the global FDR at 0.1. Then, values were log10-transformed for
the visualization purpose.
clustered in this plot. For example, all the neuropsychiatric
disorders (ADHD, ASD, BPD, MDD, and SCZ) generate a
cluster, inflammatory bowel diseases (UC and CD) make a
cluster, lipid-related phenotypes (HDL, LDL, TC, and TG)
cluster together, blood pressure phenotypes (SBP and DBP)
cluster, and so on. Moreover, RA is also located relatively
close to UC and CD, which is consistent with the literature
as RA, UC, and CD are all autoimmune diseases [11]. The
cluster containing both T2D and CAD in this plot is also
well supported by prior studies, which suggest the pleiotropy
betweenT2DandCAD [12–14].These results show the poten-
tial of the proposed GPA-MDS approach for the investigation
of pleiotropic architecture, which can be used to promote
understanding of common etiology and development of joint
treatment of diseases.
In order to further understand the phenotype mapping
provided by GPA-MDS, we checked the number of risk
SNPs shared among phenotypes (Figure 5). Here, “risk SNPs”
were determined using the GPA algorithm by controlling the
global FDR at 0.1. We can see that some of the phenotypes
that are closely located in the GPA-MDS plot actually share
more risk SNPs, as in the case of CD-UC, HDL-LDL-TG-TC,
and SBP-DBP. However, it might look like that Figure 5 seems
to contradict the GPA-MDS plot for other phenotypes. For
example, although ADHD and ASD are located really close
to each other in the GPA-MDS plot, it seems that only a few
risk SNPs are shared between these two phenotypes. Such
“discrepancy” happens because GPA evaluates pleiotropy by
checking whether the number of shared risk SNPs (𝜋11) is
significantly higher than what is expected by chance ((𝜋10 +
𝜋11)(𝜋01+𝜋11)), not simply based on the counts of shared risk
SNPs (𝜋11).
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Figure 6: MDS plot for a joint analysis of genetic studies for 18
phenotypes, based on the number of risk SNPs shared between
two phenotypes. Here, “risk SNPs” were determined using the GPA
algorithm by controlling the global FDR at 0.1.
In order to confirm this explanation and further evaluate
the utility of employing the GPA algorithm, we generated a
MDS plot of phenotypes, where the distance between two
phenotypes was determined solely by the number of shared
risk SNPs (Figure 6). Specifically, we generated the MDS plot
by defining the distance between 𝑖th and 𝑗th phenotypes as
𝑑󸀠𝑖𝑗 = 2max𝑘<𝑙{𝑛𝑘𝑙} − 𝑛𝑖𝑗, where 𝑛𝑖𝑗 is the log10-transformed
risk SNPs shared between 𝑖th and 𝑗th phenotypes. In this
mapping of phenotypes, clinically related phenotypes failed
to cluster together but instead multiple phenotype groups are
mixed together. Furthermore, we can see that the mapping
is essentially driven by a few pairs of phenotypes which
share large numbers of genotypes, such as CD-UC, TC-LDL,
and SBP-DBP. Hence, we can conclude that it was actually
critical to utilize the GPA algorithm to evaluate pleiotropy
in the first step of our visualization framework because
it provides biologically more meaningful visualization of
genetic relationship among phenotypes.
4. Conclusion
In this paper, we proposed a novel visualization approach
for genetic architecture among phenotypes, namely, GPA-
MDS, using the GPA algorithm and the multidimensional
scaling (MDS) approach. While the GPA framework pro-
vides a rigorous evaluation of pleiotropy between a pair of
phenotypes, the MDS approach extends this investigation to
larger number of phenotypes in a computationally efficient
way. The application of GPA-MDS to the genetic studies
of 18 phenotypes revealed patterns of shared genetic archi-
tecture among phenotypes, underscoring the potential of
6 International Journal of Genomics
the proposed method to investigate genetic sharing among
complex traits. We note that when the proposed GPA-MDS
framework is used, it is critical to confirm that its assumptions
hold well for the input GWAS dataset. Specifically, because
GPA-MDS uses GPA as its first step, users need to confirm
that GWAS association 𝑝-values provided to GPA-MDS
satisfy the GPA assumptions, for example, uniformity of
null 𝑝-values. For example, if population stratification and
cryptic relatedness have not been accounted for in previous
GWAS studies, 𝑝-values of null SNPs may not follow the
assumed uniform distribution and can result in biased MDS
visualization results. Hence, these confounding effects should
be checked carefully and addressed before applying the GPA-
MDS framework to these GWAS association 𝑝-values. We
recommend readers to check [6] for deeper discussion of the
GPA assumptions.
Currently, we are working on the following directions
that can further improve the GPA-MDS framework. First,
in this paper, we used a definition of distance based on the
logarithm transformation of 𝑝-values. While this approach
is intuitive and works well in practice, other choices of
distance measures might change visualization results. Hence,
it is of great interest to investigate other choices of distance
measures and their impacts on visualization results. Second,
while the proposed GPA-MDS approach promotes global
understanding of genetic architecture, it is still laborious to
pinpoint risk SNPs leading to phenotype clusters when we
investigate a large number of phenotypes. Hence, it would be
desirable to automate the procedure to identify overlapping
risk SNPs. We expect that GPA-MDS will be a useful method
in elucidating the pleiotropic architecture of complex traits,
which can contribute to a better understanding of shared
genetic mechanisms and the development of improved diag-
nosis and therapeutics.
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